Investor Relations

Company Overview

We are a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.

Our secondary operations are focused on establishing anti-depression clinics across the United Kingdom and providing business support services to similar entities in the United States and using psychiatric assessment combined with physician/medical providers to administer intravenous infusions of ketamine.

IR Contacts


Pasithea Therapeutics Corp.
1111 Lincoln Road
Suite 500
Miami Beach, FL 33139
T: 305-493-8080

Investor Relations

In-Site Communications, Inc
Lisa Carlton-Wilson
T: 917-543-9932

Transfer Agent

VStock Transfer, LLC
Pasquale Preziosa Jr
Director of On-Boarding and Corporate Actions
18 Lafayette Place
Woodmere, New York 11598
T: 212-828-8436

Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.